Road to Success

HIVE Blockchain Technologies (NASDAQ:HIVE – Get Rating) had its target price lowered by analysts at HC Wainwright from $7.00 to $5.00 in a research report issued to clients and investors on Monday, The Fly reports. HC Wainwright’s price objective points to a potential upside of 160.42% from the stock’s previous close.

A number of other brokerages have also issued reports on HIVE. Canaccord Genuity Group raised their target price on HIVE Blockchain Technologies from $5.50 to $7.00 in a research note on Monday, August 29th. TheStreet lowered HIVE Blockchain Technologies from a “c” rating to a “d+” rating in a research note on Thursday, September 1st. Canaccord Genuity Group lifted their price objective on HIVE Blockchain Technologies from $5.50 to $7.00 and gave the company a “buy” rating in a research note on Monday, August 29th. Finally, StockNews.com upgraded HIVE Blockchain Technologies to a “sell” rating in a research note on Friday, October 21st.

HIVE Blockchain Technologies Stock Performance

Shares of HIVE stock opened at $1.92 on Monday. The firm has a market capitalization of $159.41 million, a price-to-earnings ratio of -1.67 and a beta of 2.11. The company has a debt-to-equity ratio of 0.11, a current ratio of 3.75 and a quick ratio of 3.75. The business has a fifty day moving average of $2.71 and a 200 day moving average of $3.68. HIVE Blockchain Technologies has a 1 year low of $1.84 and a 1 year high of $15.80.

Hedge Funds Weigh In On HIVE Blockchain Technologies

A number of institutional investors have recently modified their holdings of HIVE. State Street Corp purchased a new position in shares of HIVE Blockchain Technologies during the 2nd quarter valued at about $1,007,000. IHT Wealth Management LLC purchased a new position in shares of HIVE Blockchain Technologies in the 3rd quarter valued at about $110,000. BlackRock Inc. increased its stake in shares of HIVE Blockchain Technologies by 25.9% in the 3rd quarter. BlackRock Inc. now owns 82,303 shares of the company’s stock valued at $310,000 after purchasing an additional 16,951 shares in the last quarter. Toroso Investments LLC increased its stake in shares of HIVE Blockchain Technologies by 132.2% in the 3rd quarter. Toroso Investments LLC now owns 25,291 shares of the company’s stock valued at $95,000 after purchasing an additional 14,400 shares in the last quarter. Finally, UBS Group AG increased its stake in shares of HIVE Blockchain Technologies by 174.5% in the 3rd quarter. UBS Group AG now owns 17,829 shares of the company’s stock valued at $67,000 after purchasing an additional 11,333 shares in the last quarter. Hedge funds and other institutional investors own 8.08% of the company’s stock.

About HIVE Blockchain Technologies

(Get Rating)

HIVE Blockchain Technologies Ltd. operates as a cryptocurrency mining company in Canada, Sweden, and Iceland. It engages in the mining and sale of digital currencies, including Ethereum, Ethereum Classic, and Bitcoin. The company was formerly known as Leeta Gold Corp. and changed its name to HIVE Blockchain Technologies Ltd.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Before you consider HIVE Blockchain Technologies, you’ll want to hear this.

MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and HIVE Blockchain Technologies wasn’t on the list.

While HIVE Blockchain Technologies currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here